Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Completed × Hyponatremia × Clear all

Phase

Phase NA 2 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 116 Neoplasms 100 Polycystic Ovary Syndrome 61 Prostatic Neoplasms 56 Colorectal Neoplasms 46 Carcinoma, Non-Small-Cell Lung 43 Pain 37 Carcinoma, Hepatocellular 34 Lung Neoplasms 31 Keratosis, Actinic 28 Precursor Cell Lymphoblastic Leukemia-Lymphoma 25 Pain, Postoperative 23 Neoplasm Metastasis 23 Stomach Neoplasms 22 Head and Neck Neoplasms 22 Brain Neoplasms 21 Pancreatic Neoplasms 20 Multiple Myeloma 19 Colonic Neoplasms 19 Leukemia, Myeloid, Acute 18 Leukemia 18 Uterine Cervical Neoplasms 17 Lymphoma, Follicular 17 Anemia 17 Lymphoma 16 Leiomyoma 16 Infertility 16 Carcinoma, Renal Cell 15 Cancer Pain 15 Lymphoma, Non-Hodgkin 14

Interventions

Tolvaptan 1 Sugars 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01199198 2020-09-23

Tolvaptan in Hyponatremic Cancer Patients

M.D. Anderson Cancer Center

Phase 4 Completed

52 enrolled 7 charts

Hyponatremia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡